Alembic Pharmaceuticals Ltd

alembic-india.com BSE: 533573 NSE : APLLTD
About [ edit ]

Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.
The company has 3 R&D and 5 manufacturing facilities.

Key Points [ edit ]
Website BSE NSE
  • Market Cap ₹ 18,025 Cr.
  • Current Price ₹ 917
  • High / Low ₹ 1,150 / 435
  • Stock P/E 15.5
  • Book Value ₹ 233
  • Dividend Yield 0.76 %
  • ROCE 24.2 %
  • ROE 29.1 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 24.99% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 24.72%
  • Company has been maintaining a healthy dividend payout of 19.59%

Cons

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
853 863 1,127 1,018 927 949 1,241 1,209 1,207 1,341 1,457 1,314
680 712 825 776 749 724 895 884 915 934 1,014 949
Operating Profit 173 151 302 242 178 225 346 325 292 407 443 365
OPM % 20% 18% 27% 24% 19% 24% 28% 27% 24% 30% 30% 28%
Other Income 1 0 2 4 3 -30 0 0 25 0 3 3
Interest 1 2 6 6 5 5 7 7 8 7 4 2
Depreciation 32 28 29 29 30 35 36 42 44 42 44 47
Profit before tax 141 122 270 211 146 155 303 276 266 360 398 318
Tax % 27% 26% 26% 19% 10% 23% 17% 18% 23% 19% 18% 19%
Net Profit 94 90 200 170 124 124 246 234 225 301 333 293
EPS in Rs 4.98 4.80 10.61 9.01 6.58 6.56 13.06 12.42 11.93 15.99 16.96 14.88
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 TTM
1,202 1,465 1,520 1,863 2,056 3,166 3,105 3,131 3,935 4,606 5,320
1,042 1,246 1,268 1,506 1,653 2,159 2,489 2,488 3,061 3,385 3,812
Operating Profit 160 219 252 358 403 1,007 616 643 874 1,221 1,508
OPM % 13% 15% 17% 19% 20% 32% 20% 21% 22% 27% 28%
Other Income 4 13 4 4 4 7 1 7 9 -37 32
Interest 28 38 15 10 4 5 5 3 18 27 21
Depreciation 30 34 35 40 44 72 83 105 115 157 176
Profit before tax 107 161 206 311 359 936 529 541 749 1,000 1,342
Tax % 20% 19% 20% 24% 21% 23% 23% 22% 21% 20%
Net Profit 85 130 165 236 283 720 403 413 584 829 1,152
EPS in Rs 6.90 8.77 12.49 15.01 38.20 21.39 21.89 31.00 43.97 59.76
Dividend Payout % 6% 20% 29% 24% 23% 9% 19% 18% 18% 23%
Compounded Sales Growth
10 Years:%
5 Years:18%
3 Years:14%
TTM:23%
Compounded Profit Growth
10 Years:%
5 Years:25%
3 Years:29%
TTM:54%
Stock Price CAGR
10 Years:%
5 Years:8%
3 Years:19%
1 Year:47%
Return on Equity
10 Years:%
5 Years:28%
3 Years:25%
Last Year:29%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions
Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Sep 2020
38 38 38 38 38 38 38 38 38 38 39
Reserves 259 357 465 638 847 1,560 1,865 2,182 2,681 3,182 4,540
Borrowings 328 353 187 109 264 114 89 708 1,128 1,747 600
246 304 358 432 493 718 698 1,013 931 1,022 1,156
Total Liabilities 844 1,052 1,048 1,217 1,641 2,429 2,689 3,941 4,778 5,989 6,336
272 268 344 397 547 708 799 993 1,158 1,552 1,815
CWIP 26 58 32 21 83 93 396 1,010 1,551 1,846 1,830
Investments 3 3 3 3 2 87 50 42 49 18 18
542 723 668 796 1,009 1,541 1,444 1,896 2,019 2,573 2,674
Total Assets 844 1,052 1,048 1,217 1,641 2,429 2,689 3,941 4,778 5,989 6,336

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
95 142 265 240 172 948 329 312 812 449
-57 -56 -67 -81 -256 -307 -486 -884 -756 -731
-47 -45 -229 -151 87 -224 -129 503 59 155
Net Cash Flow -9 41 -31 8 3 417 -286 -69 115 -127

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
ROCE % 29% 31% 44% 38% 66% 29% 22% 23% 24%
Debtor Days 61 50 56 54 64 40 40 61 45 69
Inventory Turnover 3.09 2.69 2.58 2.19 1.76 1.53 1.40 1.27 1.06

Shareholding Pattern

Numbers in percentages

Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
72.93 72.96 72.96 72.96 72.97 72.97 72.97 72.97 72.97 72.97 69.77 69.78
9.16 8.73 9.32 9.37 9.50 9.56 9.55 9.23 8.29 7.30 7.03 6.96
5.16 5.57 5.56 5.68 5.48 5.41 6.42 6.73 6.86 7.10 9.43 10.14
12.75 12.74 12.16 11.99 12.05 12.06 11.06 11.07 11.88 12.63 13.76 13.12

Documents

Add document

Recent announcements


View all

Annual reports

Credit ratings